As shown in this report, lymphoid-specific TRAF3/BCL2 double-tg mice develop B cell neoplasms, mostly DLBCL and plasma cell neoplasia, with high incidence (approximately 80% of the mice). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.